4th Quarter - Report
DENTONS US LLP for AMERISOURCEBERGEN
Firm
Client
Income
$40,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
H.R. 1483, H.R. 3026, & S. 1584 - Pharmaceutical pedigree anti-counterfeiting; H.R. 2245, S. 296. - drug shortages
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHRYN L ANDERSON | — |
| GARY L GOLDBERG | — |
| MATHEW LAPINSKI | — |
| ALEXANDER DAVID LURIE | — |
| TODD MATTHEW WEISS | — |
Taxation/Internal Revenue Code TAX
LIFO tax issues; corporate rate reform, H.R. 8
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHRYN L ANDERSON | — |
| GARY L GOLDBERG | — |
| MATHEW LAPINSKI | — |
| ALEXANDER DAVID LURIE | — |
| TODD MATTHEW WEISS | — |
Medicare/Medicaid MMM
Implementation of the Patient Protection and Affordable Care Act; issues related to Medicare drug reimbursement; S. 733 and H.R. 905, provisions related to prompt pay discounts for drugs and biologicals under Medicare Part B; ASP Generally
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHRYN L ANDERSON | — |
| GARY L GOLDBERG | — |
| MATHEW LAPINSKI | — |
| ALEXANDER DAVID LURIE | — |
| TODD MATTHEW WEISS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.